The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3206672
WO Application Number:
US2016059141
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16791778.0
WO Publication Number:
WO2017075232
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Canada (CA)
Publications:
Dates
Filing date:
27/10/2016
Grant date:
14/03/2018
EP Publication Date:
23/08/2017
WO Publication Date:
04/05/2017
Claims Translations Received Date:
Claims Translation B1 Received Date:
05/06/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/11/2020
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
14/03/2018
EP B1 Publication Date:
14/03/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
26/10/2036
Lapsed By Expiration Date:
Patent Validated Date:
22/06/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
14/03/2018
Name:
Eupraxia Pharmaceuticals Inc.
Address:
204-2590 Cadboro Bay Road, Victoria, British Columbia V8R 5J2, Canada (CA)